Literature DB >> 16934039

The NSAID roller coaster: more about rofecoxib.

J K Aronson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16934039      PMCID： PMC1885128          DOI： 10.1111/j.1365-2125.2006.02761.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  22 in total

1.  Spanish drug editor wins case brought by Merck, Sharp Dohme.

Authors:  Liza Gibson
Journal:  BMJ       Date:  2004-02-07

Review 2.  COX-3: fact or fancy?

Authors:  Francis Berenbaum
Journal:  Joint Bone Spine       Date:  2004-11       Impact factor: 4.929

3.  Obituary: John R. Vane (1927-2004).

Authors:  Salvador Moncada
Journal:  Nature       Date:  2005-01-06       Impact factor: 49.962

4.  Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.

Authors:  Nancy A Nussmeier; Andrew A Whelton; Mark T Brown; Richard M Langford; Andreas Hoeft; Joel L Parlow; Steven W Boyce; Kenneth M Verburg
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

5.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

6.  COX-2 inhibitors.

Authors:  C J Hawkey
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321

7.  NSAIDs, Cox-2 inhibitors, and the gut.

Authors:  J Hayllar; I Bjarnason
Journal:  Lancet       Date:  1995-08-26       Impact factor: 79.321

8.  Rofecoxib (Vioxx) voluntarily withdrawn from market.

Authors:  Barbara Sibbald
Journal:  CMAJ       Date:  2004-10-26       Impact factor: 8.262

9.  Selective COX-2 inhibitors and human inflammatory bowel disease.

Authors:  S A McCartney; J A Mitchell; P D Fairclough; M J Farthing; T D Warner
Journal:  Aliment Pharmacol Ther       Date:  1999-08       Impact factor: 8.171

10.  Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs.

Authors:  M J Langman; J Weil; P Wainwright; D H Lawson; M D Rawlins; R F Logan; M Murphy; M P Vessey; D G Colin-Jones
Journal:  Lancet       Date:  1994-04-30       Impact factor: 79.321
View more
  5 in total

Review 1.  Editors' review of 2006 and the BJCP prize.

Authors:  Jeffrey K Aronson; Martin S Lennard; James M Ritter; Evan J Begg; Lionel D Lewis; Michael Schachter
Journal:  Br J Clin Pharmacol       Date:  2007-01       Impact factor: 4.335

Review 2.  Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions.

Authors:  Manfred Hauben; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  Methods in clinical pharmacology.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

4.  Uncertain risks of drug related harms, the precautionary principle and limitations of meta-analysis.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2009-11       Impact factor: 4.335

5.  Non-Steroidal Anti-Inflammatory Drugs in Orthopedic Outpatient Cases in a Tertiary Care Teaching Hospital: A Descriptive Cross-sectional Study.

Authors:  Aashish Bhattarai; Krishna Raj Khanal; Jyoti Prabha Bharati
Journal:  JNMA J Nepal Med Assoc       Date:  2021-11-15       Impact factor: 0.556
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.